Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Details |  |
|---|---|
| Related links |  |
| Search |  |
Rchr
J-GLOBAL ID：202501007656504223
Update date: Mar. 17, 2025 Kojima Yuki
コジマ ユウキ | Kojima Yuki
ClipsPapers (92)
- Shu Yazaki, Yohei Chiba, Yuki Kojima, Hiroshi Yoshida, Shigemasa Takamizawa, Rui Kitadai, Ayumi Saito, Shousuke Kita, Kasumi Yamamoto, Hitomi Sumiyoshi-Okuma, et al. Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2025. 44. 2. 104-111
- Rui Kitadai, Shu Yazaki, Aya Kuchiba, Takashi Yamanaka, Sho Shiino, Chisako Yamauchi, Kenichi Harano, Motonobu Saito, Yosuke Hirotsu, Hisaki Aiba, et al. Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast Cancer. Cancer science. 2025
- Rumi Nishimura, Kazuki Sudo, Rui Kitadai, Asuka Kawachi, Munehiro Ito, Mai Hoshino, Shosuke Kita, Ayumi Saito, Yuki Kojima, Aiko Maejima, et al. Treatment and reasons for choosing treatment in breast cancer patients who underwent next-generation sequencing test. Oncology. 2025. 1-21
- Yuka Takahashi, Akihiko Yoshida, Seiichi Yoshimoto, Shigenobu Suzuki, Satsuki Kishikawa, Ayaka Mitsui, Eijitsu Ryo, Yuki Kojima, Kan Yonemori, Yasushi Yatabe, et al. TFE3-rearranged perivascular epithelioid cell tumors of the head and neck with rare fusion partners: clues to the differential diagnosis between benign and malignant tumors. Diagnostic pathology. 2025. 20. 1. 7-7
- Masaki Uchihara, Akiyo Tanabe, Yuki Kojima, Tatsunori Shimoi, Akiko Miyagi Maeshima, Kotaro Umamoto, Akihiko Shimomura, Chikako Shimizu, Yuto Yamazaki, Eijiro Nakamura, et al. Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma. Cancers. 2024. 16. 12
- Takatoshi Hirayama, Hiroto Ishiki, Yuko Yanai, Saki Horiguchi, Akiko Sugisawa, Jun Sato, Ryugo Kojima, Kaori Sato, Tomoko Mizuta, Rebekah Kojima, et al. Feasibility of an Electronic Patient-Reported Outcome Tool for Screening Distress and Supportive Care Needs of Adolescents and Young Adults with Cancer. Journal of adolescent and young adult oncology. 2024. 13. 1. 138-146
- Momoko Tokura, Mark Malalay Ando, Yuki Kojima, Rui Kitadai, Shu Yazaki, Cyrielle Marie N Atutubo, Rubi K Li, Minda Z Perez, Agnes E Gorospe, Manuelito A Madrid, et al. Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study. Breast cancer : basic and clinical research. 2024. 18. 11782234241288671-11782234241288671
- Yuki Kojima. A mobile app-based program for facilitating advance care planning discussions between patients with advanced cancer and oncologists: A randomized controlled trial (J-SUPPORT 2104). Journal of Clinical Oncology. 2024
- Yuki Kojima. A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer. npj Breast Cancer. 2024. 10. 1. 76-76
- Yuki Kojima. Clonal Architecture of circulating tumor DNA predicts Early Progression on Tamoxifen With or Without Palbociclib in Hormone Receptor-Positive Advanced Breast Cancer: NCCH1607/PATHWAY trial. Cancer Research. 2024
- Yuki Kojima. Correction: GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway. Oncogene. 2024. 43. 41. 3079-3079
- Yuki Kojima. Expression and co- expression patterns of TROP2 and HER2 in breast cancer: implications for bispecific antibody- drug conjugate therapy. Cancer Research. 2024
- Yuki Kojima. Genomic landscape of circulating tumor DNA in cervical cancer in Asia: NCCH1905/A-TRAIN trial. Cancer Research. 2024
- Yuki Kojima. Preferences for survivorship care among AYA cancer survivors and challenges of cancer specialist-led follow up. Cancer Research. 2024
- Yuki Kojima. Smartphone-based distress screening, information provision, and psychotherapy for reducing psychological distress among AYA cancer survivors: protocol for a fully decentralized multicenter randomized controlled clinical trial. Japanese Journal of Clinical Oncology. 2024. 54. 12. 1351-1357
- Yuki Kojima. Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine. Breast Cancer. 2024. 31. 6. 1037-1045
- Yuki Kojima. Neutrophillymphocyte ratio and absolute lymphocyte count, inflammatory markers, may predict lymph node metastasis in elderly patients with operable breast cancer. Cancer Research. 2024
- Yuki Kojima. Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker Analysis. Anticancer Research. 2024. 44. 5. 2125-2132
- Yuki Kojima. Trop-2 expression and the tumor immune microenvironment in cervical cancer. Gynecologic Oncology. 2024. 187. 51-57
- Yuki Kojima. Incidence of skeletal-related events in patients with Ewing sarcoma: An observational retrospective study in Japan. Cancer Medicine. 2024. 13. 5. e7060
Return to Previous Page
